Adverse reactions to levodopa: drug toxicity or progression of disease?
Identifieur interne : 001F11 ( Ncbi/Checkpoint ); précédent : 001F10; suivant : 001F12Adverse reactions to levodopa: drug toxicity or progression of disease?
Auteurs : Yves Agid [France] ; T. Chase ; D. MarsdenSource :
- Lancet (London, England) [ 0140-6736 ] ; 1998.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Antiparkinson Agents, Levodopa.
- chemical , adverse effects : Antiparkinson Agents, Levodopa.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- drug therapy : Parkinson Disease.
- Disease Progression, Humans.
DOI: 10.1016/S0140-6736(05)70285-3
PubMed: 9525359
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001476
- to stream PubMed, to step Curation: 001435
- to stream PubMed, to step Checkpoint: 001435
- to stream Ncbi, to step Merge: 001F11
- to stream Ncbi, to step Curation: 001F11
Links to Exploration step
pubmed:9525359Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adverse reactions to levodopa: drug toxicity or progression of disease?</title><author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y" last="Agid">Yves Agid</name><affiliation wicri:level="3"><nlm:affiliation>INSERM U 289 and Féderation de Neurologie-Hôpital de la Salpêtrière, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM U 289 and Féderation de Neurologie-Hôpital de la Salpêtrière, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName><placeName><settlement type="city">Paris</settlement><region type="region" nuts="2">Île-de-France</region></placeName><orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName><placeName><settlement type="city">Paris</settlement><region type="region" nuts="2">Île-de-France</region></placeName><orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName></affiliation></author><author><name sortKey="Chase, T" sort="Chase, T" uniqKey="Chase T" first="T" last="Chase">T. Chase</name></author><author><name sortKey="Marsden, D" sort="Marsden, D" uniqKey="Marsden D" first="D" last="Marsden">D. Marsden</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1998">1998</date><idno type="RBID">pubmed:9525359</idno><idno type="pmid">9525359</idno><idno type="doi">10.1016/S0140-6736(05)70285-3</idno><idno type="wicri:Area/PubMed/Corpus">001476</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001476</idno><idno type="wicri:Area/PubMed/Curation">001435</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001435</idno><idno type="wicri:Area/PubMed/Checkpoint">001435</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001435</idno><idno type="wicri:Area/Ncbi/Merge">001F11</idno><idno type="wicri:Area/Ncbi/Curation">001F11</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F11</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Adverse reactions to levodopa: drug toxicity or progression of disease?</title><author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y" last="Agid">Yves Agid</name><affiliation wicri:level="3"><nlm:affiliation>INSERM U 289 and Féderation de Neurologie-Hôpital de la Salpêtrière, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM U 289 and Féderation de Neurologie-Hôpital de la Salpêtrière, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName><placeName><settlement type="city">Paris</settlement><region type="region" nuts="2">Île-de-France</region></placeName><orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName><placeName><settlement type="city">Paris</settlement><region type="region" nuts="2">Île-de-France</region></placeName><orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName></affiliation></author><author><name sortKey="Chase, T" sort="Chase, T" uniqKey="Chase T" first="T" last="Chase">T. Chase</name></author><author><name sortKey="Marsden, D" sort="Marsden, D" uniqKey="Marsden D" first="D" last="Marsden">D. Marsden</name></author></analytic><series><title level="j">Lancet (London, England)</title><idno type="ISSN">0140-6736</idno><imprint><date when="1998" type="published">1998</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (administration & dosage)</term><term>Antiparkinson Agents (adverse effects)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Disease Progression</term><term>Humans</term><term>Levodopa (administration & dosage)</term><term>Levodopa (adverse effects)</term><term>Levodopa (therapeutic use)</term><term>Parkinson Disease (drug therapy)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Disease Progression</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement><orgName><li>Hôpital de la Salpêtrière</li></orgName></list><tree><noCountry><name sortKey="Chase, T" sort="Chase, T" uniqKey="Chase T" first="T" last="Chase">T. Chase</name><name sortKey="Marsden, D" sort="Marsden, D" uniqKey="Marsden D" first="D" last="Marsden">D. Marsden</name></noCountry><country name="France"><region name="Île-de-France"><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y" last="Agid">Yves Agid</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F11 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 001F11 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:9525359
|texte= Adverse reactions to levodopa: drug toxicity or progression of disease?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:9525359" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |